Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

  • There is currently no data for KBT

Director/PDMR Shareholding

15 Nov 2021 14:30

RNS Number : 4206S
K3 Business Technology Group PLC
15 November 2021
 

AIM: KBT

 

K3 Business Technology Group plc

("K3", "Company" or "Group")

PDMR Announcement

K3, which provides missioncritical business software and cloud solutions, has received notification from Kestrel Partners LLP ("Kestrel") that on 12 November 2021 it acquired, on behalf of its discretionary clients, 25,000 ordinary shares of 25p each ("Shares") in the Company at a price of £1.77 per Share.

Mr Scott, a non-executive director of K3, is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in one of Kestrel's clients ("Kestrel Opportunities") and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in the Company.

Following these transactions, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 8,505,879 Shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest, hold 2,602,850 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 11,108,729 Shares in the Company, which represents 24.83% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

8,505,879

19.02%

Indirect

JIM Nominees Limited

189,572

0.42%

Indirect

Bank of New York Nominees Ltd

2,413,278

5.39%

 

 

 

 

 

Further details in respect of the purchase are provided below, in accordance with the EU Market Abuse Regulation (No 596/2014) which forms part of UK Law by virtue of the European Union (Withdrawal) Act 2018.

For further information contact:

K3 Business Technology Group plc

+44 (0) 161 876 4498

Marco Vergani, CEO

 

Rob Price, CFO

 

 

 

finnCap Ltd

+44 (0) 207 220 0500

Nominated Adviser and Broker

 

 

Julian Blunt/James Thompson (Corporate finance)

 

 

Richard Chambers (Corporate Broking)

 

 

 

 

 

KTZ Communications

+44 (0) 20 3178 6378

 

Katie Tzouliadis/Dan Mahoney

 

 

 

 

ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Kestrel Partners LLP ('Kestrel')

 

2

Reason for the notification

a)

 

Position/status

 

 

PCA - Oliver Rupert Andrew Scott (non-executive director of K3 Business Technology Group plc and Partner in Kestrel)

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

K3 Business Technology Group plc

b)

 

LEI

 

213800QOJ9OF2AV81748

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

25p Ordinary Shares

 

 

 

ISIN: GB00B00P6061

b)

 

Nature of the transaction

 

Purchase

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

£1.77

25,000 - Purchase

 

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

Total purchase of 25,000 at £1.77 for value £44,250.00

 

e)

 

Date of the transaction

 

12/11/2021

f)

 

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHXELFFFFLXFBD
Date   Source Headline
1st Apr 20207:00 amRNSLoan Funding Secured and Update on Subsidiary
24th Mar 20207:00 amRNSDelay to Final Results
21st Feb 202011:28 amRNSHolding(s) in Company
18th Feb 20203:10 pmRNSDirector/PDMR Shareholding
17th Feb 202012:32 pmRNSBoard Appointment
6th Feb 20204:13 pmRNSBoard Changes
28th Oct 20196:15 pmRNSPDMR Announcement
24th Oct 20192:09 pmRNSDirector/PDMR Shareholding
22nd Oct 20192:00 pmRNSPrice Monitoring Extension
22nd Oct 20197:00 amRNSTrading update
12th Jul 20194:41 pmRNSPDMR Announcement
9th Jul 20197:00 amRNSInterim Results
18th Jun 20197:00 amRNSTrading Update
23rd May 20198:48 amRNSPDMR Announcement
22nd May 20192:05 pmRNSResult of AGM
19th Mar 20197:00 amRNSFinal Results
8th Feb 20192:42 pmRNSPDMR Dealings
22nd Jan 20191:06 pmRNSHolding(s) in Company
17th Dec 20187:00 amRNSTrading Update
29th Oct 20183:05 pmRNSHolding(s) in Company
20th Aug 20186:15 pmRNSHolding(s) in Company
9th Jul 20187:00 amRNSInterim Results
13th Jun 201810:44 amRNSHolding(s) in Company
11th Jun 20187:00 amRNSContracts Wins
7th Jun 20187:00 amRNSCapital Markets Afternoon & Notice of Results
30th May 201811:02 amRNSResult of AGM
30th May 20187:00 amRNSAGM Statement
6th Apr 20183:40 pmRNSHolding(s) in Company
5th Apr 20184:36 pmRNSPDMR Dealings
27th Mar 20187:00 amRNSFinal Results (17 months)
5th Mar 20183:48 pmRNSHolding(s) in Company
5th Jan 20189:50 amRNSHolding(s) in Company
27th Dec 20172:19 pmRNSDirector/PDMR Shareholding
12th Dec 20177:00 amRNSTrading Update
27th Sep 20177:00 amRNSSecond Interim Results
26th Sep 201711:52 amRNSHolding(s) in Company
18th Sep 201711:17 amRNSHolding(s) in Company
8th Aug 20173:55 pmRNSHolding(s) in Company
6th Jul 20175:25 pmRNSHolding(s) in Company
6th Jul 201710:48 amRNSPDMR Shareholding
6th Jul 20179:05 amRNSHolding(s) in Company
5th Jul 20171:17 pmRNSHolding(s) in Company
4th Jul 201711:41 amRNSReplacement:Result of General Meeting
4th Jul 201711:11 amRNSSIP Announcement
4th Jul 201711:06 amRNSResult of General Meeting
4th Jul 201710:36 amRNSHolding(s) in Company
4th Jul 20177:00 amRNSSigning of Facility Amendment Agreement
30th Jun 20177:00 amRNSResult of Open Offer
12th Jun 201712:58 pmRNSResults of Proposed Placing
12th Jun 20177:00 amRNSFundraising & Board Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.